Sun exposure left a woman in "insufferable pain"

TL;DR

Emily Pearson suffered from erythropoietic protoporphyria (EPP), a rare disorder causing extreme pain from sun exposure.
For years, her life was limited by the need to constantly protect herself from sunlight.
She participated in a clinical trial for bitopertin, a drug that lowers protoporphyrin IX levels in the skin.
The medication has dramatically increased her sun tolerance, enabling her to run a marathon and enjoy outdoor activities without severe pain.
Bitopertin is currently in Phase 3 clinical trials, with Disc Medicine awaiting further data for FDA review.

Continue lendo o artigo original